Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

āshibio Exits Stealth Mode With $40 Million In Funding Led By Mpm Bio Impact, Appoints Pankaj Bhargava As CEO

PRIVATEJun 20, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

āshibio

Pankaj Bhargava
CambridgeBiotechnologyHealth CareTherapeutics

Description

Privately held biotechnology company āshibio exited stealth mode today with $40 million in seed and Series A financing led by MPM BioImpact. In addition, Dr. Pankaj Bhargava, founder of the company, has been appointed as Chief Executive Officer.

Company Information

Company

āshibio

Location

Cambridge, Massachusetts, United States

About

āshibio is a privately held biotechnology company focused on developing innovative therapeutics for bone and connective tissue disorders. The company is dedicated to advancing development of several investigative therapies, including a potential treatment for fibrodysplasia ossificans progressiva (FOP), a rare genetic disease characterized by severe and progressive heterotopic ossification.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for āshibio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.